Virtual Reality and Meditation for Fibromyalgia
Primary Purpose
Fibromyalgia
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Virtual Reality Meditation
Non-VR Meditation
Sponsored by
About this trial
This is an interventional treatment trial for Fibromyalgia focused on measuring Fibromyalgia, Virtual Reality, Meditation, Pain
Eligibility Criteria
Inclusion Criteria:
- Adults ages 18 and older (no upper limit)
- Diagnosis of fibromyalgia with a minimum average pain level of 3 over the last week
- English-speaking
- Willing and able to visit the Brigham and Women's Pain Management Center site on two separate occasions to participate in the study
Exclusion Criteria:
- Unwilling to put on VR headset
- Experience a seizure in the last 5 years
- Cognitive impairment
- Hearing/visual deficit
- Active, contagious skin infection
- Eye infections
- Has a pacemaker or defibrillator
- Has a hearing aid
- History of myocardial infarction or other serious cardiovascular condition
- Current peripheral neuropathy
Sites / Locations
- Brigham and Women's Pain Management Center
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
VR first
VR second
Arm Description
At their first visit, subjects will engage in a virtual reality meditation while wearing the VR headset. At their second visit, they will engage in a non-immersive meditation without the 3D VR aspect.
At their first visit, subjects will engage in a non-immersive meditation without the 3D VR aspect. At their second visit, they will engage in a virtual reality meditation while wearing the VR headset.
Outcomes
Primary Outcome Measures
Pain Numerical Rating Scale [NRS] (change from pre-intervention to post-intervention)
Measures the intensity of pain on an 11-point scale, ranging from 0-10. 0 is "no pain", and 10 is "pain as bad as you can imagine".
Secondary Outcome Measures
Baseline Survey
Obtains demographics, medical history, perceptions/attitudes of pain, and experiences with VR.
Brief Pain Inventory-Short Form
Fifteen-item self-report questionnaire that measures participant's various levels of pain severity in the past 24 hours, and perception of the degree to which pain prevents participation in important daily activities (e.g. work, socialization) and enjoyment of life. Eight pain severity items are rated on a 11-point scale of 0 (no pain) to 10 (pain as bad as you can imagine). Seven pain interference items are rated on a 11-point scale of 0 (does not interfere) to 10 (completely interferes).
Pain Catastrophizing Scale [PCS]
Thirteen-item self-report questionnaire that collects data on the types of thoughts and feelings the participants have when in pain. The participants will be asked to rank the degree to which they have certain thoughts and feelings when they are in pain using a 5-point Likert scale, from 0 (not at all) to 4 (all the time).
PROMIS Emotional Distress - Short Form
24-item self report questionnaire that measures how often participant experiences feelings related to depression, anxiety and anger in the past seven days. These questionnaires have been modified to ask about the past 24 hours. The questionnaire uses a 5-point Likert scale, from 1 (never) to 5 (always). This questionnaire will assess the participant's psychological state.
Fibromyalgia Impact Questionnaire (FIQ)
10-item self-report questionnaire that measures the functional impacts FM had on the participants' life over the last 7 days. Items relate to physical functioning and physical symptoms, as well as psychological impact of FM, and occupational interference.
Simulator Sickness Questionnaire [SSQ]
List of sixteen symptoms which are commonly experienced by users of virtual reality systems. Participants rate the severity of these symptoms while using the VR system using a 4-point Likert scale from 1 (none) to 4 (severe). This questionnaire will monitor the extent of motion sickness in our participants.
Meditation Experience Questionnaire (MEQ)
Thirteen-item self-report questionnaire that asks subjects to rate the frequency of occurrence of various experiences, such as fatigue, pleasant/unpleasant thoughts, and thoughts about planning or memories, during meditation intervention to evaluate quality of meditation immersion. Uses 5-point Likert scale from 1 (never) to 5 (almost constantly).
User Engagement Scale (UES)
Twelve-item self-report questionnaire that measures the participant's perception of how engaged they were with the experience using a 5-point Likert scale from 1 (strongly disagree) to 5 (strongly agree). This questionnaire will determine immersion into the meditation.
Positive and Negative Affect Scale [PANAS]
This ten-item self-report questionnaire measures the extent to which the participant felt various emotions right now. This questionnaire uses a 5-point Likert scale, from 1 (very slightly or not at all) to 5 (extremely). This questionnaire will assess the participant's psychological state.
Quantitative Sensory Testing (QST)
Measurements of pain thresholds for bilateral trapezius muscles using a pressure algometer and measurement of temporal summation using a Neuropen on the non-dominant middle finger.
Blood Pressure
Systolic and Diastolic blood pressure will be obtained using an automated BP cuff.
Heart Rate
Heart rate will be obtained using an automated BP cuff.
Full Information
NCT ID
NCT05512650
First Posted
August 12, 2022
Last Updated
August 22, 2022
Sponsor
Tufts University
Collaborators
Brigham and Women's Hospital, Rheumatology Research Foundation
1. Study Identification
Unique Protocol Identification Number
NCT05512650
Brief Title
Virtual Reality and Meditation for Fibromyalgia
Official Title
Use of Virtual Reality for Musculoskeletal Pain
Study Type
Interventional
2. Study Status
Record Verification Date
August 2022
Overall Recruitment Status
Completed
Study Start Date
May 31, 2022 (Actual)
Primary Completion Date
August 2, 2022 (Actual)
Study Completion Date
August 2, 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Tufts University
Collaborators
Brigham and Women's Hospital, Rheumatology Research Foundation
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Fibromyalgia (FM) is a particularly debilitating rheumatological syndrome which affects millions of adults in the United States. The condition presents with widespread chronic muscular pain and reduced pain thresholds, fatigue, insomnia, and negative affect. Chronic pain that is caused by FM can have significant effects on physical function, psychological parameters, and overall quality of life. Currently, there is a need for safe and effective non-pharmacologic pain-management strategies for FM, and research has shown that virtual reality (VR) may be a useful tool for some of these clients. The literature has suggested improvements in pain scores on a visual analog scale (VAS) for adults with a variety of rheumatological issues, including FM. Additional research has demonstrated that affect was improved for clients with FM who participated in a 10-minute VR mindfulness session. Such findings highlight the potential benefits of VR and mindfulness meditation for clients with FM. However, there is a great deal that remains unknown about the effectiveness of these pain management techniques. Therefore, this pilot study will examine and compare the effectiveness of combining VR and meditation for improving symptoms of FM in adults. We hypothesize that a VR meditation session will facilitate greater improvements in pain, affect, and physiological vital stats as compared to a non-immersive meditation intervention.
Detailed Description
Current treatments for fibromyalgia (FM) include pharmaceutical pain medications (ranging from over the counter to prescription opioids) as well as psychological programs with components of relaxation, cognitive therapy, and activity management. However, pain medications are not fully effective, can be addictive, and can cause hyperalgesia, and there is little research on psychological interventions for FM.
One treatment that has demonstrated some efficacy for reducing chronic pain is meditation. Various studies have demonstrated that there are generally reductions in affective pain for those who practice meditation. Another promising treatment option for FM is virtual reality (VR). VR is an immersive 3D experience during which the participant wears a headset or helmet which simulates the sensation of being elsewhere. There is evidence which shows that VR can be an effective treatment for pain reduction. However, most studies which utilize VR as a method of pain reduction focus on acute pain and studies looking at VR for chronic pain are scarce.
One preliminary study examined the utility of VR in treating FM. Results from this study showed that positive affect increased after participants engaged in a 10-minute meditation and mindfulness VR session. Further, they found a slight reduction in the negative impact of FM on overall life and wellbeing, as measured by the FM Impact Questionnaire (FIQ). However, small sample sizes and the addition of other adjunctive therapies limit the significance of these study results. Additional research on VR and meditation for the treatment of FM and other rheumatological conditions also demonstrated reductions in pain scores, offering promising data on meditation and VR being used in combination.
Given the promising literature on VR and meditation, this study will aim to further the field of knowledge surrounding use of VR meditation for reducing pain and increasing affect for adults with FM. Despite the encouraging data on using these interventions for FM, it is unknown whether the immersive aspect of the VR is helping to improve results. This pilot study will aim to address this question by comparing an immersive VR meditation session with a non-immersive, typical meditation for FM patients.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Fibromyalgia
Keywords
Fibromyalgia, Virtual Reality, Meditation, Pain
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
9 (Actual)
8. Arms, Groups, and Interventions
Arm Title
VR first
Arm Type
Active Comparator
Arm Description
At their first visit, subjects will engage in a virtual reality meditation while wearing the VR headset. At their second visit, they will engage in a non-immersive meditation without the 3D VR aspect.
Arm Title
VR second
Arm Type
Active Comparator
Arm Description
At their first visit, subjects will engage in a non-immersive meditation without the 3D VR aspect. At their second visit, they will engage in a virtual reality meditation while wearing the VR headset.
Intervention Type
Device
Intervention Name(s)
Virtual Reality Meditation
Intervention Description
Participants will be set up in the VR equipment. They will engage and follow along with a 10-20 minute guided meditation through the VR. The meditation program may include simulated movement, relaxing music, and the voice of a meditation guide. The research team member will supervise the session, ensuring safety of the subject is maintained.
Intervention Type
Device
Intervention Name(s)
Non-VR Meditation
Intervention Description
Participants will engage and follow along with a 10-20 minute guided meditation on a computer screen placed before them. The meditation program may include simulated movement visuals, relaxing music, and the voice of a meditation guide. The research team member will supervise the session, ensuring safety of the subject is maintained.
Primary Outcome Measure Information:
Title
Pain Numerical Rating Scale [NRS] (change from pre-intervention to post-intervention)
Description
Measures the intensity of pain on an 11-point scale, ranging from 0-10. 0 is "no pain", and 10 is "pain as bad as you can imagine".
Time Frame
Pre-intervention and within 20 minutes after intervention at both visits.
Secondary Outcome Measure Information:
Title
Baseline Survey
Description
Obtains demographics, medical history, perceptions/attitudes of pain, and experiences with VR.
Time Frame
Pre-intervention at visit 1
Title
Brief Pain Inventory-Short Form
Description
Fifteen-item self-report questionnaire that measures participant's various levels of pain severity in the past 24 hours, and perception of the degree to which pain prevents participation in important daily activities (e.g. work, socialization) and enjoyment of life. Eight pain severity items are rated on a 11-point scale of 0 (no pain) to 10 (pain as bad as you can imagine). Seven pain interference items are rated on a 11-point scale of 0 (does not interfere) to 10 (completely interferes).
Time Frame
Pre-intervention at both visits.
Title
Pain Catastrophizing Scale [PCS]
Description
Thirteen-item self-report questionnaire that collects data on the types of thoughts and feelings the participants have when in pain. The participants will be asked to rank the degree to which they have certain thoughts and feelings when they are in pain using a 5-point Likert scale, from 0 (not at all) to 4 (all the time).
Time Frame
Pre-intervention at visit 1.
Title
PROMIS Emotional Distress - Short Form
Description
24-item self report questionnaire that measures how often participant experiences feelings related to depression, anxiety and anger in the past seven days. These questionnaires have been modified to ask about the past 24 hours. The questionnaire uses a 5-point Likert scale, from 1 (never) to 5 (always). This questionnaire will assess the participant's psychological state.
Time Frame
Pre-intervention at both visits
Title
Fibromyalgia Impact Questionnaire (FIQ)
Description
10-item self-report questionnaire that measures the functional impacts FM had on the participants' life over the last 7 days. Items relate to physical functioning and physical symptoms, as well as psychological impact of FM, and occupational interference.
Time Frame
Pre-intervention at visit 1.
Title
Simulator Sickness Questionnaire [SSQ]
Description
List of sixteen symptoms which are commonly experienced by users of virtual reality systems. Participants rate the severity of these symptoms while using the VR system using a 4-point Likert scale from 1 (none) to 4 (severe). This questionnaire will monitor the extent of motion sickness in our participants.
Time Frame
Within 20 minutes after intervention at both visits.
Title
Meditation Experience Questionnaire (MEQ)
Description
Thirteen-item self-report questionnaire that asks subjects to rate the frequency of occurrence of various experiences, such as fatigue, pleasant/unpleasant thoughts, and thoughts about planning or memories, during meditation intervention to evaluate quality of meditation immersion. Uses 5-point Likert scale from 1 (never) to 5 (almost constantly).
Time Frame
Within 20 minutes after intervention at both visits.
Title
User Engagement Scale (UES)
Description
Twelve-item self-report questionnaire that measures the participant's perception of how engaged they were with the experience using a 5-point Likert scale from 1 (strongly disagree) to 5 (strongly agree). This questionnaire will determine immersion into the meditation.
Time Frame
Within 20 minutes after intervention at both visits.
Title
Positive and Negative Affect Scale [PANAS]
Description
This ten-item self-report questionnaire measures the extent to which the participant felt various emotions right now. This questionnaire uses a 5-point Likert scale, from 1 (very slightly or not at all) to 5 (extremely). This questionnaire will assess the participant's psychological state.
Time Frame
Pre-intervention and within 20 minutes after intervention at both visits.
Title
Quantitative Sensory Testing (QST)
Description
Measurements of pain thresholds for bilateral trapezius muscles using a pressure algometer and measurement of temporal summation using a Neuropen on the non-dominant middle finger.
Time Frame
Pre-intervention and within 10 minutes after intervention at both visits.
Title
Blood Pressure
Description
Systolic and Diastolic blood pressure will be obtained using an automated BP cuff.
Time Frame
Pre-intervention and immediately after intervention at both visits.
Title
Heart Rate
Description
Heart rate will be obtained using an automated BP cuff.
Time Frame
Pre-intervention and immediately after intervention at both visits.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Adults ages 18 and older (no upper limit)
Diagnosis of fibromyalgia with a minimum average pain level of 3 over the last week
English-speaking
Willing and able to visit the Brigham and Women's Pain Management Center site on two separate occasions to participate in the study
Exclusion Criteria:
Unwilling to put on VR headset
Experience a seizure in the last 5 years
Cognitive impairment
Hearing/visual deficit
Active, contagious skin infection
Eye infections
Has a pacemaker or defibrillator
Has a hearing aid
History of myocardial infarction or other serious cardiovascular condition
Current peripheral neuropathy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nancy A Baker
Organizational Affiliation
Tufts University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Brigham and Women's Pain Management Center
City
Chestnut Hill
State/Province
Massachusetts
ZIP/Postal Code
02467
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
31872189
Citation
Venuturupalli RS, Chu T, Vicari M, Kumar A, Fortune N, Spielberg B. Virtual Reality-Based Biofeedback and Guided Meditation in Rheumatology: A Pilot Study. ACR Open Rheumatol. 2019 Nov 11;1(10):667-675. doi: 10.1002/acr2.11092. eCollection 2019 Dec.
Results Reference
background
PubMed Identifier
23496678
Citation
Botella C, Garcia-Palacios A, Vizcaino Y, Herrero R, Banos RM, Belmonte MA. Virtual reality in the treatment of fibromyalgia: a pilot study. Cyberpsychol Behav Soc Netw. 2013 Mar;16(3):215-23. doi: 10.1089/cyber.2012.1572.
Results Reference
background
PubMed Identifier
31306747
Citation
Ahmadpour N, Randall H, Choksi H, Gao A, Vaughan C, Poronnik P. Virtual Reality interventions for acute and chronic pain management. Int J Biochem Cell Biol. 2019 Sep;114:105568. doi: 10.1016/j.biocel.2019.105568. Epub 2019 Jul 12.
Results Reference
background
PubMed Identifier
24892201
Citation
Herrero R, Garcia-Palacios A, Castilla D, Molinari G, Botella C. Virtual reality for the induction of positive emotions in the treatment of fibromyalgia: a pilot study over acceptability, satisfaction, and the effect of virtual reality on mood. Cyberpsychol Behav Soc Netw. 2014 Jun;17(6):379-84. doi: 10.1089/cyber.2014.0052.
Results Reference
background
PubMed Identifier
22398352
Citation
Hennard J. A protocol and pilot study for managing fibromyalgia with yoga and meditation. Int J Yoga Therap. 2011;(21):109-21.
Results Reference
background
PubMed Identifier
21303476
Citation
Ngian GS, Guymer EK, Littlejohn GO. The use of opioids in fibromyalgia. Int J Rheum Dis. 2011 Feb;14(1):6-11. doi: 10.1111/j.1756-185X.2010.01567.x. Epub 2010 Aug 23.
Results Reference
background
Links:
URL
https://www.cdc.gov/arthritis/basics/fibromyalgia.htm
Description
Centers for Disease Control (CDC) on Fibromyalgia
Learn more about this trial
Virtual Reality and Meditation for Fibromyalgia
We'll reach out to this number within 24 hrs